An open-labeled, multicentric clinical study of cetuximab combined with intensity-modulated radiotherapy (IMRT) plus concurrent chemotherapy in locoregionally advanced (LA) nasopharyngeal carcinoma (NPC): A 2-year follow-up report | |
Chen, Chun-yan; Zhao, Chong; Gao, Li; Lang, Jin-yi; Pan, Jian-ji; Hu, Chao-su; Jin, Feng; Wang, Ren-sheng; Xie, Conghua; Lin, Tongyu | |
2012 | |
卷号 | 30期号:15 |
ISSN号 | 0732-183X |
URL标识 | 查看原文 |
收录类别 | SCIE |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/6707153 |
专题 | 中国医学科学院 北京协和医学院 |
推荐引用方式 GB/T 7714 | Chen, Chun-yan,Zhao, Chong,Gao, Li,et al. An open-labeled, multicentric clinical study of cetuximab combined with intensity-modulated radiotherapy (IMRT) plus concurrent chemotherapy in locoregionally advanced (LA) nasopharyngeal carcinoma (NPC): A 2-year follow-up report[J],2012,30(15). |
APA | Chen, Chun-yan.,Zhao, Chong.,Gao, Li.,Lang, Jin-yi.,Pan, Jian-ji.,...&Lu, Tai-xiang.(2012).An open-labeled, multicentric clinical study of cetuximab combined with intensity-modulated radiotherapy (IMRT) plus concurrent chemotherapy in locoregionally advanced (LA) nasopharyngeal carcinoma (NPC): A 2-year follow-up report.,30(15). |
MLA | Chen, Chun-yan,et al."An open-labeled, multicentric clinical study of cetuximab combined with intensity-modulated radiotherapy (IMRT) plus concurrent chemotherapy in locoregionally advanced (LA) nasopharyngeal carcinoma (NPC): A 2-year follow-up report".30.15(2012). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论